Featured Guests
Paul Armentano

Paul Armentano is deputy director of NORML, and the National Organization for the Reform of Marijuana Laws, and a...

Ben Cort

Ben Cort is business development manager for the Center for Addiction Recovery and Rehabilitation (CeDAR), part of the University...

Your Host
J. Craig Williams

J. Craig Williams is admitted to practice law in Iowa, California, Massachusetts, and Washington. Before attending law school, his...

In a recent decision, the Drug Enforcement Administration ruled that marijuana will remain a Schedule 1 substance under the Controlled Substances Act. Substances in Schedule 1 are determined by the Food and Drug Administration to be drugs with no currently accepted medical use and a high potential for abuse.  

On Lawyer 2 Lawyer, host J. Craig Williams joins Paul Armentano, deputy director of NORML and Ben Cort, business development manager for the Center for Addiction Recovery and Rehabilitation (CeDAR), to discuss the recent decision by the DEA to keep marijuana on the Schedule 1 list. They will talk impact, the legalization of marijuana, manufacturing marijuana for scientific purposes, and what the future holds on this controversial topic.

Paul Armentano is deputy director of NORML, and the National Organization for the Reform of Marijuana Laws, and a senior policy advisor at Freedom Leaf, Inc: The Marijuana Legalization Company. He is the co-author of the book “Marijuana is Safer: So Why Are We Driving People to Drink?” Paul was also the principal investigator for defense counsel in U.S. v Schweder, the first federal evidentiary since 1973 hearing to challenge the constitutionality of cannabis as a schedule I controlled substance.

Ben Cort is business development manager for the Center for Addiction Recovery and Rehabilitation (CeDAR), part of the University of Colorado Health system. Ben’s passion for recovery, prevention and harm reduction comes from his own struggle with substance abuse. Sober since 1996, Cort is also a junior fellow at the University of Florida’s Drug Policy Institute and serves on the boards of Project SAM (Smart Approaches to Marijuana) and the Stout Street Foundation.

Special thanks to our sponsor, Clio.


Full Transcript

 View Transcript

Brought to You by
Episode Details
Published: September 30, 2016
Podcast: Lawyer 2 Lawyer
Category: Legal News , Medical Law
This Podcast
Lawyer 2 Lawyer
Lawyer 2 Lawyer

Lawyer 2 Lawyer is a legal affairs podcast covering contemporary and relevant issues in the news with a legal perspective.

  iTunes   Google Play
More Episodes
11/22/17
Inside the Mueller Investigation

Mark Zaid and Douglas Kmiec discuss the recent charges in Robert Mueller’s investigation into Russian involvement in the 2016 Presidential campaign.

10/27/17
Take a Knee Movement, the NFL, and the First Amendment

Alan Milstein and Marc Randazza discuss the Take a Knee controversy, players’ rights, the First Amendment, President Trump’s reaction, and the NFL’s role.

10/20/17
The Legal Issues Stemming from the Las Vegas Tragedy

Bob Ambrogi talks to Tennille Pereira and Kristin Tyler about the legal issues stemming from the Las Vegas tragedy.

09/29/17
Legal Implications of the Equifax Data Breach

Drew Rossow and Ben Meiselas discuss the Equifax data breach, what went wrong, litigation, the potential impact, and what customers need to do.

09/15/17
DACA, DREAMers, and the Threat of Deportation

Hans von Spakovsky and Erin J. Lee discuss DACA and the Dream ACT, and what the future holds for DREAMers and their families.

09/01/17
First Amendment’s Clash with Censorship and Hate Speech

In this legal podcast, Robert Bertsche and Eugene Volokh define First Amendment, and how it relates to censorship and hate speech.